Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL

Topics: 

Citation
Clegg LE et al. Diabetes Jun 2019;68(Supplement 1):6-LB.